Archives

Cordis, a Cardinal Health company, today announced the U.S. launch of MYNX CONTROL™ Vascular Closure Device (VCD). MYNX CONTROL™ VCD integrates active...

Cardinal Health (NYSE: CAH) today announced that Victor Crawford will be joining the company as its next CEO of the Pharmaceutical Segment. Victor's most recent role was Chief Operating Officer,...

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2019 on November 8 prior to the opening of trading on the New York Stock Exchange. The company will...

The inaugural Women Pharmacist Day will be commemorated on Oct. 12, 2018, in conjunction with National Pharmacist Month, to recognize the important contributions women pharmacists make, every day,...

Cardinal Health announced that Ola Snow will become chief human resources officer for the company, following the departure of Pamela Kimmet, who is leaving the...

The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to shareholders of record at the close...

Cardinal Health (NYSE: CAH) today reported fourth-quarter fiscal year 2018 revenues of $35 billion, an increase of 7 percent from the fourth quarter last year, and fiscal year 2018 revenues of...

Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2018 on August 6 prior to the opening of trading on the New York Stock Exchange. The...

The Cardinal Health Foundation today announced that it has awarded over $3 million in grants to more than 70 nonprofit organizations to support local efforts to combat the opioid epidemic across Ohio,

Cardinal Health, Inc. (NYSE: CAH) and Clayton, Dubilier & Rice ("CD&R") announced today that CD&R-managed funds will jointly invest with Cardinal Health in naviHealth, the largest manager of...